(Q36996783)

17 August 2017

1 reference

title

Pediatric non-Hodgkin's lymphoma (English)

1 reference

17 August 2017

Thomas G Gross

1

1 reference

PubMed ID

17991353

17 August 2017

Amanda M Termuhlen

series ordinal

2

1 reference

17 August 2017

1 November 2007

1 reference

17 August 2017

Current Oncology Reports

1 reference

17 August 2017

9

1 reference

17 August 2017

6

1 reference

17 August 2017

459-465

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-007-0064-6

17 August 2017

0 references

cites work

MALT lymphoma in children: a report from the NHL-BFM Study Group

1 reference

12 December 2020

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

1 reference

12 December 2020

Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature

1 reference

12 December 2020

Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report

1 reference

12 December 2020

Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution

1 reference

12 December 2020

Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group

1 reference

12 December 2020

Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial

1 reference

12 December 2020

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

1 reference

12 December 2020

Relapses of childhood anaplastic large-cell lymphoma: Treatment results in a series of 41 children - a report from the French Society of Pediatric Oncology

1 reference

12 December 2020

Assessment of minimal residual disease in childhood non-hodgkin lymphoma by polymerase chain reaction using patient-specific primers.

1 reference

12 December 2020

Three children with CD30 cutaneous anaplastic large cell lymphomas bearing the t(2;5)(p23;q35) translocation

1 reference

12 December 2020

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

1 reference

12 December 2020

The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.

1 reference

12 December 2020

Primary central nervous system lymphoma in children

1 reference

12 December 2020

Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia

1 reference

12 December 2020

Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms

1 reference

12 December 2020

Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.

1 reference

12 December 2020

Non-Hodgkin's lymphoma in childhood

1 reference

12 December 2020

The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia

1 reference

12 December 2020

Translocations involving anaplastic lymphoma kinase (ALK).

1 reference

12 December 2020

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

1 reference

12 December 2020

Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation

1 reference

12 December 2020

Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia

1 reference

12 December 2020

Second malignancy after treatment of childhood non-Hodgkin lymphoma

1 reference

12 December 2020

Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group

1 reference

12 December 2020

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

1 reference

12 December 2020

Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non Hodgkin's lymphoma: a Pediatric Oncology Group study

1 reference

12 December 2020

Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group

1 reference

12 December 2020

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

12 December 2020

Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

1 reference

12 December 2020

Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials.

1 reference

12 December 2020

Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?

1 reference

12 December 2020

The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence

1 reference

12 December 2020

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

1 reference

12 December 2020

ALK+ lymphoma: clinico-pathological findings and outcome.

1 reference

12 December 2020

Molecular diagnosis of Burkitt's lymphoma

1 reference

12 December 2020

Treatment of children and young adults with early-stage non-Hodgkin's lymphoma

1 reference

12 December 2020

Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

1 reference

12 December 2020

Report of the Committee on Hodgkin's Disease Staging Classification

1 reference

12 December 2020

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

1 reference

12 December 2020

Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

1 reference

12 December 2020

Clinicopathologic analysis of follicular lymphoma occurring in children

1 reference

12 December 2020

Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III tri

1 reference

12 December 2020

10.1007/S11912-007-0064-6

Identifiers

DOI

1 reference

release_dfs7f2mofrhe5bip22vmums3c4

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dfs7f2mofrhe5bip22vmums3c4

24 November 2022

mapped directly with Wikidata item

PubMed ID

17991353

1 reference

PubMed ID

17991353